Who owns MIMEDX GROUP, INC. (MDXG)? Elite investor 13F holders

3 tracked elite investors reported holding MIMEDX GROUP, INC as of 2026-06-30, including Renaissance Technologies LLC, Cannell Capital, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines,…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Renaissance Technologies LLCMIMEDX GROUP INCSHARE2026-06-302026-08-13 00:00:009410285.00 USD2444230.000000SharesreduceOriginal filing
Cannell CapitalMIMEDX GROUP INCSHARE2026-06-302026-08-18 00:00:007201179.00 USD1870436.000000SharesaddOriginal filing
D.E. ShawMIMEDX GROUP INCSHARE2026-06-302026-08-14 00:00:001622263.00 USD421367.000000SharesaddOriginal filing
Tudor InvestmentMIMEDX GROUP INCSHARE2026-06-302026-08-14 00:00:000.00 USD0.000000SharesexitedOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown